医药生物行业:拥抱创新药大时代 积极围绕Q2业绩布局

中泰证券股份有...
04 Jun

5 月回顾:多重事件催化下创新药行情进一步高涨。2025 年5 月医药生物板块上涨6.4%,同期沪深300 上涨1.8%,医药板块跑赢沪深300 指数4.6%,位列31 个子行业第2 位。本月所有子板块均上涨,化学制药、生物制品、医疗服务、中药、医疗器械、医药商业分别上涨9.77%、7.29%、6.00%、4.11%、3.63%、1.12%。5 月20日,三生制药与辉瑞就PD-1/VEGF 双抗...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10